Gene · 11167
Papers1,795
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,795
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identifying pyroptosis-related genes as novel therapeutic targets in diabetic foot ulceration. | Diabetol Metab Syndr | 2025 | 40750912 | PubTator, text mining | PubMed |
| Comparative transcriptomic and genomic analysis of tumor cells in the marginal and center regions of tumor nests in human hepatocellular carcinoma. | Front Cell Dev Biol | 2025 | 40741331 | PubTator, text mining | PubMed |
| Modeling Aberrant Angiogenesis in Arteriovenous Malformations Using Endothelial Cells and Organoids for Pharmacological Treatment. | Cells | 2025 | 40710334 | PubTator, text mining | PubMed |
| Loss of p300 in proximal tubular cells reduces renal fibrosis and endothelial-mesenchymal transition. | EMBO Mol Med | 2025 | 40588562 | PubTator, text mining | PubMed |
| Key mediators of the efficacy of mesenchymal stem cells on in vivo disease models. | Cell Transplant | 2025 | 40560652 | PubTator, text mining | PubMed |
| Revealing Potential Therapeutic Targets in Gastric Cancer through Inflammation and Protein-Protein Interaction Hub Networks. | J Cancer | 2025 | 40535808 | PubTator, text mining | PubMed |
| FSTL-1 as a Novel Cardiokine of Cardiac Angiogenesis: A Systematic Review. | Vasc Health Risk Manag | 2025 | 40453420 | PubTator, text mining | PubMed |
| Correlation of FSTL1 and its paralogs with body composition in adult survivors of childhood cancer. | Sci Rep | 2025 | 40447699 | PubTator, text mining | PubMed |
| Decoding the Liver-Heart Axis in Cardiometabolic Diseases. | Circ Res | 2025 | 40403112 | PubTator, text mining | PubMed |
| Cardiovascular System is Influenced by Skeletal Muscle-derived Extracellular Vesicles, Myokines and MicroRNAs Based on Interorgan Communication: A Systematic Review. | Int J Med Sci | 2025 | 40386050 | PubTator, text mining | PubMed |
| Stem cell therapies in the clinic. | Bioeng Transl Med | 2025 | 40385529 | PubTator, text mining | PubMed |
| Investigation of the Pathogenesis of Liver Fibrosis Associated with Type 2 Diabetes Mellitus via Bioinformatic Analysis. | Biomedicines | 2025 | 40299397 | PubTator, text mining | PubMed |
| P2Y6 promoted pruning of FSTL1 nerves by cutaneous macrophages to reset pain threshold and cardiac function. | Purinergic Signal | 2025 | 40293604 | PubTator, text mining | PubMed |
| Interplay Between Diet, Branched-Chain Amino Acids, and Myokines in Children: Vegetarian Versus Traditional Eating Habits. | Nutrients | 2025 | 40077702 | PubTator, text mining | PubMed |
| Host FSTL1 defines the impact of stem cell therapy on liver fibrosis by potentiating the early recruitment of inflammatory macrophages. | Signal Transduct Target Ther | 2025 | 40050288 | PubTator, text mining | PubMed |
| Finding Potential Drug Targets for Pre-Eclampsia Using Mendelian Randomisation and Colocalisation Analysis. | Am J Reprod Immunol | 2025 | 40028697 | PubTator, text mining | PubMed |
| Transcytosis of LDL Across Arterial Endothelium: Mechanisms and Therapeutic Targets. | Arterioscler Thromb Vasc Biol | 2025 | 40013359 | PubTator, text mining | PubMed |
| FSTL1 accelerates nucleus pulposus-derived mesenchymal stem cell apoptosis in intervertebral disc degeneration by activating TGF-β-mediated Smad2/3 phosphorylation. | J Transl Med | 2025 | 40011941 | PubTator, text mining | PubMed |
| Case-Control Study: Evaluating the Role and Therapeutic Potential of FSTL1 in Type 2 Inflammation of Chronic Rhinosinusitis. | J Inflamm Res | 2025 | 39995823 | PubTator, text mining | PubMed |
| Renal tubular epithelial-derived follistatin-like 1 protects against UUO-induced renal fibrosis in mice via inhibiting NF-κB-mediated epithelial inflammation. | Theranostics | 2025 | 39990230 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11167/papers?page=5